FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Bupropion Hydrochloride Tablets
Status: Discontinuation
»Therapeutic Categories: Psychiatry

Expand all

Mylan Pharmaceuticals Inc. (New 06/19/2018)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
Extended-release tablets, 100 mg, 100 count bottle (NDC 0378-3411-01) 06/19/2018 The discontinuation of this product is a business decision.
Extended-release tablets, 100 mg, 500 count bottle (NDC 0378-3411-05) 06/19/2018 The discontinuation of this product is a business decision.
Extended-release tablets, 150 mg, 100 count bottle (NDC 0378-5521-01) 06/19/2018 The discontinuation of this product is a business decision.
Extended-release tablets, 150 mg, 100 count bottle (NDC 0378-3412-01) 06/19/2018 The discontinuation of this product is a business decision.
Extended-release tablets, 150 mg, 500 count bottle (NDC 0378-3412-05) 06/19/2018 The discontinuation of this product is a business decision.
Extended-release tablets, 200 mg, 100 count bottle (NDC 0378-3413-01) 06/19/2018 The discontinuation of this product is a business decision.
Extended-release tablets, 200 mg, 500 count bottle (NDC 0378-3413-05) 06/19/2018 The discontinuation of this product is a business decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English